EPS Phase 4
Phase 4 of EPS allows prescriptions for patients without an EPS nomination to be signed, sent and processed electronically.
The initial phase of EPS Phase 4 roll out to GP practices in England is taking place from 18th November to 13th December 2019. This phase is going to national deployment with approx. 5% of TPP prescribing sites only.
Following a review over the Christmas period to ensure the success criteria has been met with this initial implementation, a further 10% of TPP sites will be enabled from January 2020. NHS Digital will continue to work with all four GP system suppliers, who have all developed Phase 4 functionality in order to achieve national deployment for all prescribing systems in 2020.
This deployment makes EPS the default method for prescribing, dispensing and reimbursement of prescriptions in primary care in England. Although the sites will initially be in specific areas, patients can choose to take their token to any pharmacy in England.
All dispensers need to be aware of EPS Phase 4 tokens. GP practices will soon be able to use EPS for patients without a nomination, with patients receiving a Phase 4 token with a scannable barcode instead of a signed FP10.
Phase 4 token barcodes should be scanned and dispensed as any other electronic prescription.
As with all EPS prescriptions, dispense notifications and endorsements need to be added to the electronic prescription using your pharmacy system. Endorsements written or printed onto any type of EPS token will not be processed by the NHS Business Services Authority.
Benefits for dispensers
The benefits for dispensers include:
- Most of your prescriptions will be processed electronically to reduce dual processing
- One main process for prescriptions will lead to a more efficient, faster and secure service
- End-of-month processing will be quicker due to fewer paper prescriptions
- Reduced risk of dispensing duplicate prescriptions as electronic prescriptions can’t be lost
- Great prescription tracking with EPS Prescription Tracker